@Barcode:$Novavax(NVAX)$ 🚀 $NVAX, Escaping the Doom Loop? A Speculative LEAPS Play in the Making 🔥 Novavax, $NVAX, has been stuck in a brutal downtrend, battered by financial struggles, market scepticism, and relentless volatility. But is this biotech underdog finally bottoming out? The technical setup suggests a potential shift, with the stock hovering around key support levels and signs of exhaustion in selling pressure. Meanwhile, implied volatility remains lofty at 84%, signalling wild swings ahead. I am eyeing January 2027 LEAPS as a speculative way to play what could be a long-term reversal. If NVAX regains traction, this could be a high-risk, high-reward opportunity. Let’s break it down: 🛠 The Technical Setup, Cracks in the Downtrend? NVAX has been

@Darren Charley:$NIO Inc.(NIO)$ In 2020 all the analysts were targeting NIO at $75 or more. At the time they knew NIO had no sedans, no factory (JAC contracted ES6 and ES8 builds) and was limited to 7000 units a month. Covid limited capacity and sales. Fast forward to 2025, NIO is averaging 17,000 units a month, has developed a supply chain second to none and is widely considered the leader in EV tech.